Nanoceut Therapeutics Private Limited, a active private limited company, was established on 04 November 2010 in Sedarapet, Pondicherry, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24230PY2010PTC002523. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Employing 48 professional, Its leadership includes Krishna Kumar Abboy (Managing Director), Haripriya (Director). Past directors included Abboy Gunabai, Ramya Periasamy, Subasri Sundaravelu. It holds ₹10.99 Cr open charges and ₹10.23 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at R.S. No.104/19A, E V R Street, Sedarapet, Pondicherry, 605111.
U24230PY2010PTC002523
002523
04 November 2010
₹2.00 Cr
₹2.00 Cr
Roc Pondicherry
Unlisted
Active
Explore comprehensive insights into Nanoceut Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Kumar Abboy | Managing Director | 01 Feb 2018 | Current |
| Haripriya | Director | 26 May 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 23 May 2014 | Past |
| Pramod Abcsdd | Director | 30 Jun 2014 | Past |
| Pramod Abcsdd | Director | 23 May 2014 | Past |
| Pramod Abcsdd | Director | 23 Jul 2024 | Past |
| Pramod Abcsdd | Director | 30 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nanoceut Therapeutics Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 5.34% increase. The company also saw a substantial improvement in profitability, with a 64.56% increase in profit. The company's net worth Soared by an impressive increase of 22.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Nanoceut Therapeutics had a public holding of 95.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹109,936,000.00
₹102,332,700.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2024 | Indian Bank | ₹9.24 Cr | Open |
| 25 Apr 2023 | Sidbi | ₹1.75 Cr | Open |
| 22 Sep 2023 | Others | ₹3.34 M | Satisfied |
| 22 Sep 2023 | Others | ₹1.00 Cr | Satisfied |
| 29 Apr 2023 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Nanoceut Therapeutics has a workforce of 48 employees as of Mar 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nanoceut Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nanoceut Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Indian Bank of Rs. 9.24 Cr registered on 02 Dec 2024 with Charge ID 101033299 was modified on 12 May 2025. was completed.
The activity A charge registered on 22 Sep 2023 via Charge ID 100799602 with Others was fully satisfied on 02 Jan 2025. was completed.
Progress on A charge registered on 22 Sep 2023 via Charge ID 100799582 with Others was fully satisfied on 02 Jan 2025. was documented.
A charge registered on 29 Apr 2023 via Charge ID 100741603 with Others was fully satisfied on 02 Jan 2025. was recorded as a recent event.
Progress on A charge with Indian Bank amounted to Rs. 9.24 Cr with Charge ID 101033299 was registered on 02 Dec 2024. was documented.
Nanoceut Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The CIN of Nanoceut Therapeutics Private Limited is U24230PY2010PTC002523.
Nanoceut Therapeutics Private Limited is headquartered at R.S. No.104/19A, E V R Street, Sedarapet, Pondicherry, 605111.
Nanoceut Therapeutics Private Limited was incorporated on 04 November 2010.
The current directors of Nanoceut Therapeutics Private Limited are
The primary industry of Nanoceut Therapeutics Private Limited is Manufacturing.
Nanoceut Therapeutics Private Limited is unlisted.
The authorized capital of Nanoceut Therapeutics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Nanoceut Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX